Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 1/2005

01-01-2005 | Case Report

A case of brucellar septic arthritis of the knee with a prolonged clinical course

Authors: Ergin Ayaşlıoğlu, Özlem Özlük, Dilek Kılıç, Sedat Kaygusuz, Simay Kara, Gülümser Aydın, Fügen Çokca, Emin Tekeli

Published in: Rheumatology International | Issue 1/2005

Login to get access

Abstract

Brucellosis is a systemic infectious disease with a broad spectrum of clinical manifestations. Arthritis is frequently observed in its course and may be one of the main presenting clinical features of the disease. We report a case of brucellar monoarthritis of the knee with a prolonged clinical course despite efficient antibiotic treatment.
Literature
1.
Taşova Y, Saltoğlu N, Şahin G, Aksu HS (1999) Osteoarticular involvement of brucellosis in Turkey. Clin Rheumatol 18:214–219CrossRefPubMed
2.
McGill PE (2003) Geographically specific infections and arthritis, including rheumatic syndromes associated with certain fungi and parasites, Brucella species and Mycobacterium leprae. Best Pract Res Clin Rheumatol17:289–307CrossRef
3.
Andonopoulos AP, Asımakopoulos G, Anastasiou E, Bassaris HP (1986) Brucella arthritis. Scand J Rheumatol 15:377–380PubMed
4.
Press J, Peled N, Buskila D, Yagupsky P (2002) Leukocyte count in the synovial fluid of children with culture-proven brucellar arthritis. Clin Rheumatol 21:191–193CrossRefPubMed
5.
Bannatyne RM, Jackson MC, Memish Z (1997) Rapid diagnosis of Brucella bacteremia by using the BACTEC 9240 system. J Clin Microbiol 35:2673–2674PubMed
6.
Yagupsky P, Peled N, Press J (2000) Use of BACTEC 9240 blood culture system for detection of B. melitensis in synovial fluid. J Clin Microbiol 39:738–741CrossRef
7.
Morata P, Queipo-Ortuno MI, Reguera JM, Miralles F, Lopez-Gonzalez JJ, Colmenero JD (2001) Diagnostic yield of a PCR assay in focal complications of brucellosis. J Clin Microbiol 39:3743–3746CrossRefPubMed
8.
Wirtz DC, Marth M, Miltner O, Schneider U, Zilkens KW (2001) Septic arthritis of the knee in adults: treatment by arthroscopy or arthrotomy. Int Orthop 25:239–241CrossRefPubMed
9.
Solera J, Martinez-Alfaro E, Espinosa A (1997) Recognition and optimum treatment of brucellosis. Drugs 53:245–256PubMed
Metadata
Title
A case of brucellar septic arthritis of the knee with a prolonged clinical course
Authors
Ergin Ayaşlıoğlu
Özlem Özlük
Dilek Kılıç
Sedat Kaygusuz
Simay Kara
Gülümser Aydın
Fügen Çokca
Emin Tekeli
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0453-1

Other articles of this Issue 1/2005

Rheumatology International 1/2005 Go to the issue

Original Article

Tumoral calcinosis revisited: pathophysiology and treatment

Case Report

A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis

Case Report

Multiple avascular necrosis of bone and polyarticular septic arthritis in patients with systemic lupus erythematosus

Original Article

Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis

Reply to letter to the editor

Nerve conduction tests in patients with fibromyalgia: comparison with normal controls

Original Article

Mud compress therapy for the hands of patients with rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits